Alpha-fetoprotein (AFP)-Producing Gastric Cancer

Oncology

Prevalence

10.0 / 100K

Incidence

6.1 / 100K/yr

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Alpha-fetoprotein (AFP)-Producing Gastric Cancer?

There are 1 clinical trial targeting Alpha-fetoprotein (AFP)-Producing Gastric Cancer tracked by BioSniper.

What is the prevalence of Alpha-fetoprotein (AFP)-Producing Gastric Cancer?

The estimated prevalence of Alpha-fetoprotein (AFP)-Producing Gastric Cancer is approximately 10.0 per 100,000 population.

Deep-dive into Alpha-fetoprotein (AFP)-Producing Gastric Cancer

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Alpha-fetoprotein (AFP)-Producing Gastric Cancer — Drugs in Development & Clinical Trials | BioSniper